Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- Inside a legendary healthcare dealmaker's next chapter;
- Investors are pouring millions into online abortion care startups;
- How 3 concerning variants that have emerged since Delta compare.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Shannon Stapleton/Reuters; Patient Square Capital; Bobby Yip/Reuters; Samantha Lee/Insider
Jim Momtazee walked away from private equity giant KKR to strike out on his own. Now the legendary healthcare dealmaker is poised to break records with his new firm.
- Jim Momtazee was KKR's top healthcare dealmaker before leaving the private equity giant in 2019.
- Momtazee now has his own firm and is aiming to raise a record-setting $3 billion first fund.
- Healthcare is a red-hot sector. But, the pandemic has made it even harder for new investment firms to raise funds.
The abortion pill is legal in all fifty states.
Cavan Images/ Getty Images
Cavan Images/ Getty Images
Startup founders and VCs are stepping up as states like Texas restrict abortion access
- As Texas restricts abortion care, companies are raising millions to offer the service online.
- Hey Jane, Choix, and Just the Pill prescribe abortion medication online.
- Venture backers say these sites could be an entryway into the lucrative women's healthcare market.
A medical worker performs a PCR test for COVID-19 on August 31, 2020, at a testing booth in Montreuil, France.
Alain Jocard/AFP/Getty Images
Alain Jocard/AFP/Getty Images
3 concerning variants have caught scientists' attention since Delta emerged - here's how they compare
- Three coronavirus variants - Lambda, Mu, and C.1.2 - have raised red flags among scientists lately.
- The variants show signs of being highly transmissible, able to circumvent vaccine protection, or both.
- But so far, none is more concerning than Delta, the world's dominant strain.
More stories we're reading:
- Pfizer picked a COVID-19 vaccine dose far lower than Moderna's to minimize side effects, its top scientist says (Insider)
- Verily's at a critical moment where it needs to turn its biggest ideas into a profitable business (Stat News)
- Theranos founder Elizabeth Holmes' fraud trial is now underway. Here are some of the big players listed as potential witnesses in the case. (Insider)
- Dollar General CEO: About 65% of the discount retailer's stores are in "health deserts" (CNBC)
- Lydia
Read the original article on Business Insider